These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy. Cure S; Guerra I; Cammà C; Craxì A; Carosi G J Med Econ; 2015; 18(9):678-90. PubMed ID: 25891129 [TBL] [Abstract][Full Text] [Related]
24. Patient with decompensated hepatitis C virus-related cirrhosis delisted for liver transplantation after successful sofosbuvir-based treatment. Ruiz I; Feray C; Pawlotsky JM; Hézode C Liver Transpl; 2015 Mar; 21(3):408-9. PubMed ID: 25420476 [No Abstract] [Full Text] [Related]
25. Hemodialysis patients with hepatitis C infection are not receiving the new antiviral medications. Goodkin DA; Bieber B Am J Nephrol; 2015; 41(4-5):302. PubMed ID: 26044708 [No Abstract] [Full Text] [Related]
26. Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea. Cho Y; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ Clin Mol Hepatol; 2015 Dec; 21(4):358-64. PubMed ID: 26770924 [TBL] [Abstract][Full Text] [Related]
29. Seizures as a Potential Complication of Treatment With Simeprevir and Sofosbuvir. Syal G; Heldenbrand SD; Duarte-Rojo A Am J Ther; 2016; 23(2):e570-1. PubMed ID: 25549078 [TBL] [Abstract][Full Text] [Related]
30. Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir. Bernuth S; Yagmur E; Schuppan D; Sprinzl MF; Zimmermann A; Schad A; Kittner JM; Weyer V; Knapstein J; Schattenberg JM; Wörns MA; Galle PR; Zimmermann T Dig Liver Dis; 2016 Mar; 48(3):291-7. PubMed ID: 26514736 [TBL] [Abstract][Full Text] [Related]
32. The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C. Gentile I; Maraolo AE; Buonomo AR; Zappulo E; Borgia G Expert Opin Drug Discov; 2015 Dec; 10(12):1363-77. PubMed ID: 26563720 [TBL] [Abstract][Full Text] [Related]
33. Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection. Tang L; Ward H; Kattakuzhy S; Wilson E; Kottilil S Expert Rev Gastroenterol Hepatol; 2016; 10(1):21-36. PubMed ID: 26558305 [TBL] [Abstract][Full Text] [Related]